To advance the development of the vaccine candidate through early clinical development, including the necessary preparatory activities and execution of studies.
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93025C00033
- Awardee
-
Appili Therapeutics USA Inc. UEI HREVE7N46SM8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,605,418
Award facts
- Contract value 100% obligated
- $3,605,418.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Office of Logisitics and Acquisition Operations National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 26 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21704, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $3,605,418 |
About this award
The Office of Logistics and Acquisition Operations awarded a definitive contract to Appili Therapeutics USA Inc. for vaccine candidate development through early clinical development on September 30, 2025, with a ceiling value of $3,605,418.
The contract covers preparatory activities and execution of studies to advance the vaccine candidate through early clinical development. Place of performance is Frederick, MD. The contract is priced on a cost-plus-fixed-fee basis with an ultimate completion date of July 2, 2026.
Quick answers
Who was awarded contract 75N93025C00033?
75N93025C00033 was awarded to Appili Therapeutics USA Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 30, 2025.
How much is contract 75N93025C00033 worth?
The government has obligated $3,605,418 on 75N93025C00033.
Which agency awarded contract 75N93025C00033?
National Institute of Allergy and Infectious Diseases (National Institutes of Health) awarded 75N93025C00033, with funding from Office of Logisitics and Acquisition Operations (National Institutes of Health).
Was contract 75N93025C00033 competed?
The extent of competition for 75N93025C00033 was full and open competition. The government received 26 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award